Technology
Bionical Emas Sells EMAS Pharma To Kester Capital Following Strategic Review
(MENAFN - GlobeNewsWire - Nasdaq) Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global ...
By: menafn
- Dec 09 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS